Suppr超能文献

与伪造同行评审相关的撤稿特征概述

Characteristics of retractions related to faked peer reviews: an overview.

作者信息

Qi Xingshun, Deng Han, Guo Xiaozhong

机构信息

Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.

Postgraduate College, Dalian Medical University, Dalian, China.

出版信息

Postgrad Med J. 2017 Aug;93(1102):499-503. doi: 10.1136/postgradmedj-2016-133969. Epub 2016 Sep 23.

Abstract

A faked peer review is a novel cause for retraction. We reviewed the characteristics of papers retracted due to a faked peer review. All papers retracted due to faked peer reviews were identified by searching the website and by conducting a manual search. All identified papers were confirmed in published journals. The information of retracted papers was collected, which primarily included publisher, journal, journal impact factor, country, as well as publication and retraction year. Overall, 250 retracted papers were identified. They were published in 48 journals by six publishers. The top 5 journals included the (24.8%), (11.6%), (8.0%), (6.8%) and (6.4%). The publishers included SAGE (31%), Springer (26%), BioMed Central (18%), Elsevier (13%), Informa (11%) and LWW (1%). A minority (4%) of retracted papers were published in with an impact factor of >5. A majority (74.8%) of retracted papers were written by Chinese researchers. In terms of the publication year, the retracted papers were published since 2010, and the number of retracted papers peaked in 2014 (40.8%). In terms of the retraction year, the retractions started in 2012, and the number of retractions peaked in 2015 (59.6%). The number of papers retracted due to faked peer reviews differs largely among journals and countries. With the improvement of the peer review mechanism and increased education about publishing ethics, such academic misconduct may gradually disappear in future.

摘要

虚假同行评审是论文撤稿的一个新原因。我们回顾了因虚假同行评审而撤稿的论文的特征。通过搜索网站和人工检索,确定了所有因虚假同行评审而撤稿的论文。所有确定的论文均在已发表的期刊中得到证实。收集了撤稿论文的信息,主要包括出版商、期刊、期刊影响因子、国家以及发表和撤稿年份。总体而言,共确定了250篇撤稿论文。它们由6家出版商发表在48种期刊上。排名前5的期刊包括《[期刊名1]》(24.8%)、《[期刊名2]》(11.6%)、《[期刊名3]》(8.0%)、《[期刊名4]》(6.8%)和《[期刊名5]》(6.4%)。出版商包括SAGE(31%)、施普林格(26%)、生物医学中心(18%)、爱思唯尔(13%)、英富曼(11%)和Lippincott Williams & Wilkins(1%)。少数(4%)撤稿论文发表在影响因子>5的期刊上。大多数(74.8%)撤稿论文由中国研究人员撰写。就发表年份而言,撤稿论文自2010年起发表,撤稿论文数量在2014年达到峰值(40.8%)。就撤稿年份而言,撤稿始于2012年,撤稿数量在2015年达到峰值(59.6%)。因虚假同行评审而撤稿的论文数量在期刊和国家之间差异很大。随着同行评审机制的完善和出版伦理教育的加强,这种学术不端行为未来可能会逐渐消失。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验